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Introduction
CD95 (APO-1/Fas) is a member of the death receptor (DR) fam-
ily, a subfamily of the TNF-R superfamily (Lavrik et al., 2005a). 
Cross-linking of CD95 with its natural ligand CD95L (CD178; 
Suda et al., 1993) or with agonistic antibodies such as anti– 
APO-1 induces apoptosis in sensitive cells (Trauth et al., 1989). 
Stimulation of CD95 has also been reported to induce nonapop-
totic pathways such as NF-B, Akt, Erk, and others (Peter et al., 
2007). The death-inducing signaling complex (DISC) is formed 
within seconds after CD95 stimulation (Kischkel et al., 1995). The 
DISC comprises oligomerized, and probably trimerized, CD95 
and the adaptor protein FADD, two isoforms of procaspase-8   
(procaspase-8a and procaspase-8b), procaspase-10, and cellular 
FADD-like interleukin-1–converting enzyme inhibitory pro-
teins  (c-FLIPs)  long/short/Raji  (c-FLIPL/S/R;  Muzio  et  al., 
1996;  Scaffidi  et  al.,  1999;  Sprick  et  al.,  2002;  Krammer   
et al., 2007). The interactions between the molecules at the 
DISC are based on homotypic contacts. The death domain of 
CD95 interacts with the death domain of FADD, whereas the 
death effector domain (DED) of FADD interacts with the   
N-terminal tandem DEDs of procaspase-8, procaspase-10, and 
the c-FLIP isoforms.
After binding to the DISC, procaspase-8a/b (p55/p53) under-
goes autocatalytic processing, resulting in the generation of   
active caspase-8 (Muzio et al., 1996; Medema et al., 1997; Lavrik   
et al., 2005b). This processing involves dimerization of two   
procaspase-8 molecules followed by a conformational change, lead-
ing to autoactivation of procaspase-8 homodimers (Muzio et al., 
1998; Chang et al., 2003; Fuentes-Prior and Salvesen, 2004). Dur-
ing subsequent procaspase-8–processing steps at the DISC, cleav-
age occurs at several Asp (D) residues between the prodomain and 
the small and large catalytic subunits (Fig. 1 A). This results in   
the formation of the N-terminal cleavage product p43/p41, the 
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catalytically inactive caspase-like domains (p20 and p12).   
In addition to their antiapoptotic role in DR-induced apoptosis, 
c-FLIP proteins were demonstrated to play a prominent role in 
engagement of NF-B signaling (Budd et al., 2006; Neumann 
et al., 2010). Remarkably, two cleavage products of c-FLIP, 
p43-FLIP and p22-FLIP (Fig. 1 A), were shown to play an im-
portant role in NF-B induction (Kataoka and Tschopp, 2004; 
Dohrman et al., 2005; Golks et al., 2006).
c-FLIP proteins are recruited to the DISC by DED inter-
actions. Both short c-FLIP isoforms, c-FLIPS and c-FLIPR, block 
DR-induced apoptosis by inhibiting procaspase-8 activation   
at the DISC (Krueger et al., 2001; Golks et al., 2005; Ueffing 
et al., 2008). This has been suggested to occur via formation   
of catalytically inactive procaspase-8/c-FLIPR/S heterodimers. 
The role of c-FLIPL at the DISC is still a matter of controversy 
(Yu and Shi, 2008). It has been shown that c-FLIPL can act as   
an antiapoptotic molecule, functioning in a way analogous to   
c-FLIPS when expressed at high concentrations in the cell (Krueger 
et al., 2001; Chang et al., 2002). It has also been reported that   
c-FLIPL can act as a proapoptotic molecule when expressed at 
prodomain p26/p24, and the C-terminal cleavage products p30, 
p18, and p10 (Medema et al., 1997; Hoffmann et al., 2009; Hughes 
et al., 2009). Active caspase-8 heterotetramers p102-p182 generated 
at the DISC trigger the apoptotic signal. Recently, it has been re-
ported that the cleavage products p30 and p43/p41 also possess 
catalytic activity, which leads to apoptosis initiation (Hoffmann   
et al., 2009; Hughes et al., 2009). Thus, procaspase-8 processing 
at the DISC initiates apoptosis through generation of several cata-
lytically active cleavage products.
Procaspase-10 is also activated at the DISC. However, it 
was reported to be unable to induce apoptosis in the absence   
of procaspase-8 (Sprick et al., 2002). Therefore, the role of 
procaspase-10 in regulation of apoptosis remains unclear.
c-FLIP is a well-described inhibitor of DR-mediated apop-
tosis (Scaffidi et al., 1999; Krueger et al., 2001; Golks et al., 2005). 
At the mRNA level, it can be found in multiple splice variants, 
whereas at the protein level, only three isoforms, c-FLIPL,   
c-FLIPS, and c-FLIPR, have been detected so far (Fig. 1 A). All 
three c-FLIP isoforms contain two DEDs structurally similar   
to the N-terminal part of procaspase-8. c-FLIPL also contains 
Figure  1.  c-FLIP  isoforms  have  different   
effects  on  caspase-8  activation  at  the  DISC. 
(A) Scheme of the DED proteins of the DISC, 
procaspase-8,  and  c-FLIP  and  their  cleav-
age  products.  Procaspase-8  proteins  com-
prise  two  isoforms (procaspase-8a [p55] and   
procaspase-8b [p53]) and their cleavage prod-
ucts, p43/p41, p30, and p18. c-FLIP proteins 
comprise three isoforms, namely c-FLIPL, c-FLIPS, 
and c-FLIPR, and two c-FLIP cleavage products 
(p43-FLIP  and  p22-FLIP).  (B)  HeLa-CD95, 
HeLa-CD95–FL, and HeLa-CD95–FR cells were 
stimulated with 1 µg/ml LZ-CD95L for the indi-
cated time points. CD95 DISCs were immuno-
precipitated  using  anti–APO-1  antibodies 
and analyzed along with total cellular lysates 
using Western blotting (WB) with antibodies 
against caspase-8 (C15), c-FLIP (NF6), FADD 
(1C4), and CD95 (C20). (C) HeLa-CD95 and 
HeLa-CD95–FL cells were stimulated with the 
indicated amounts of LZ-CD95L. CD95 DISCs 
were immunoprecipitated 20 min after addi-
tion of LZ-CD95L using anti–APO-1 antibodies 
and analyzed along with total cellular lysates 
using Western blotting with antibodies against 
caspase-8 (C15), c-FLIP (NF6), FADD (1C4), 
and  CD95  (C20).  (D)  HeLa  wt  (dark  gray 
bars), HeLa-CD95 (black bars), HeLa-CD95–FL 
(light  gray  bars),  and  HeLa-CD95–FR  (white 
bars) cells were stimulated with the indicated 
amounts of LZ-CD95L. Specific cell death was 
determined after 24 h of CD95 stimulation with 
PI stain and flow cytometry. Mean and SEM 
of three independent experiments are shown. 
(E) HeLa-CD95 and HeLa-CD95–FL cells were 
stimulated with 200 ng/ml LZ-CD95L for the in-
dicated time points. Total cellular lysates were 
analyzed  using  Western  blotting  with  anti-
bodies against caspase-8, caspase-3, cleaved 
PARP,  and  actin.  (F)  HeLa-CD95  and  HeLa-
CD95–FL cells were stimulated with 3 µg/ml 
LZ-CD95L for the indicated time points. Total 
cellular lysates were analyzed using Western 
blotting  with  antibodies  against  caspase-8, 
caspase-3, cleaved PARP, and actin. (B, C, E, 
and F) One representative experiment out of 
three is shown. White lines indicate that inter-
vening lanes have been spliced out.379 Interplay of c-FLIP proteins decides life or death • Fricker et al.
unprocessed  procaspase-8a/b  (p55/p53)  was  detected  at  the 
DISC. Even after several hours of stimulation, procaspase-8 at 
the DISC was only processed to a minor extent (Fig. S1 C). 
Another short isoform of c-FLIP, c-FLIPS, blocked procas-
pase-8 activation in a similar way (unpublished data). There-
fore, we considered that c-FLIPS and c-FLIPR act in a uniform 
manner on caspase-8 activation and did not distinguish be-
tween the two short isoforms in our further work. Strikingly, 
overexpression of c-FLIPL (HeLa-CD95–FL cells), accelerated 
the  first  cleavage  step  of  procaspase-8a/b  processing  at  the 
DISC. The entire pool of procaspase-8a/b at the DISC was pro-
cessed to p43/p41 already after 20 min of stimulation (Fig. 1 B). 
These data were in accordance with previous studies that   
demonstrated similar effects on procaspase-8 activation at the 
DISC upon overexpression of the long or short c-FLIP isoforms 
(Krueger et al., 2001; Micheau et al., 2002; Golks et al., 2005).
A remarkably similar activating effect of c-FLIPL on   
procaspase-8 cleavage at the DISC was observed upon addition 
of different doses of LZ-CD95L (Fig. 1 C). Independent of the 
amount of LZ-CD95L, procaspase-8a/b was completely cleaved 
to p43/p41 after 20 min of stimulation at the DISC of HeLa-
CD95–FL cells. In contrast, in HeLa-CD95 cells, most of the 
procaspase-8 at the DISC had not been processed at this time 
point. We also observed an increase of procaspase-8 cleavage 
products in the lysates of HeLa-CD95–FL cells compared with 
HeLa-CD95 cells after 20 min of stimulation at all ligand con-
centrations used (Fig. 1 C). The same results were obtained for 
independent clones of HeLa-CD95–FL cells (Fig. S1 D).
Although c-FLIPL accelerated procaspase-8 cleavage at 
the DISC, the sensitivity of HeLa-CD95–FL cells toward CD95-
induced death was reduced in comparison with HeLa-CD95 
cells (Fig. 1 D). However, HeLa-CD95–FL cells were more sen-
sitive than HeLa-CD95–FR cells (Fig. 1 D), which is in accor-
dance with Western blot data on procaspase-8 processing in 
these cell lines (Fig. 1 B).
Because there was a decrease in CD95-mediated cell 
death after c-FLIPL overexpression, although initial procaspase-8 
cleavage was accelerated, we aimed to get more insight into   
this  phenomenon. We  analyzed  the  kinetics  of  procaspase-8 
processing in the lysate for longer time periods. Upon addition 
of 200 ng/ml LZ-CD95L, procaspase-8 cleavage occurred in 
HeLa-CD95  cells  after  120  min  but  was  almost  completely 
blocked  in  HeLa-CD95–FL  cells  (Fig.  1  E).  Caspase-3  and 
poly(ADP-ribose) polymerase (PARP) cleavage were also sig-
nificantly impaired. This was in accordance with the decreased 
cell death in HeLa-CD95–FL cells for low concentrations of 
CD95L (Fig. 1 D).
However, upon stimulation with a high amount of 3 µg/ml 
LZ-CD95L, not only the formation of the procaspase-8 cleavage 
products p43/p41, p30, and p18 was accelerated in total cellular 
lysates of HeLa-CD95–FL cells (Fig. 1 F), but also the amount of 
caspase-3 and PARP cleavage products was slightly higher in 
HeLa-CD95–FL cells. To test whether this increase in procaspase-8 
and procaspase-3 processing led to an acceleration of the   
induction of cell death, we measured cell death upon stimulation 
with 3 µg/ml or 200 ng/ml LZ-CD95L in HeLa-CD95 and HeLa-
CD95–FL cells at various time points (Fig. S2 A). Induction of 
low concentrations, facilitating the activation of procaspase-8 at 
the DISC (Chang et al., 2002). This has been reported to be me-
diated by formation of catalytically active procaspase-8/c-FLIPL 
heterodimers in which the procaspase-8 active loop is stabilized 
by c-FLIPL (Micheau et al., 2002; Yu et al., 2009), thereby allow-
ing cleavage of procaspase-8 into p43/41. However, this proapop-
totic role of c-FLIPL contradicts the findings of Sharp et al. 
(2005), who have demonstrated that the selective knockdown   
of c-FLIPL sensitizes the cells toward DR-induced apoptosis. 
These findings motivated us to apply a more systematic ap-
proach to understand how different quantities of c-FLIP pro-
teins at the DISC influence caspase-8 activation at the DISC and 
subsequent apoptosis induction.
Studies of apoptosis using systems biology have recently 
provided significant insight in cell death. There are several 
models describing the regulation of caspase activation (Eissing 
et al., 2004; Legewie et al., 2006), the intrinsic pathway (Rehm 
et al., 2006), and death pathway regulation (Bentele et al., 2004; 
Spencer et al., 2009). However, a detailed model considering 
the dynamics of all DED proteins, e.g., procaspase-8 and   
c-FLIP, at the DISC was still missing.
Based on quantitative Western blot data, we built a mathe-
matical model of CD95 DISC signaling. The model made several 
important predictions, which were confirmed experimentally.   
In this way, we show that the same amount of c-FLIPL can ac-
celerate cell death at high CD95L concentrations, whereas it 
slows down induction of cell death at low CD95L concentra-
tions. We demonstrate that c-FLIPL acts proapoptotic in the 
presence of high amounts of one of the short c-FLIP isoforms. 
Our data show that c-FLIPL can abrogate the c-FLIPR/S–mediated 
inhibition of procaspase-8 processing. Thus, we found a novel 
function of the short c-FLIP isoforms: they modulate the sensi-
tizing effect of c-FLIPL.
Results
c-FLIPL can accelerate caspase-8 
activation, whereas c-FLIPR/S inhibits it
To understand the influence of the three c-FLIP isoforms on 
procaspase-8 activation (Fig. 1 A), we generated HeLa cell lines 
stably overexpressing CD95 along with different c-FLIP iso-
forms, c-FLIPL, c-FLIPS, or c-FLIPR (HeLa-CD95–FL, HeLa-
CD95–FS, or HeLa-CD95–FR, respectively). The expression of 
all other main components of the CD95 DISC (CD95, FADD, 
and procaspase-8) was similar in these cell lines (Fig. S1 A). 
Surface expression of CD95 was also uniform in the different 
HeLa-CD95 cell lines (Fig. S1 B).
To  analyze  procaspase-8  activation,  HeLa-CD95–FL, 
HeLa-CD95–FR, and HeLa-CD95 cells were stimulated for dif-
ferent time intervals with 1 µg/ml LZ-CD95L. This was fol-
lowed by analysis of the CD95 DISCs and total cellular lysates 
on Western blots (Fig. 1 B). In HeLa-CD95 cells, procaspase-8a/b 
processing at the DISC occurred as described in a previous 
study with generation of the cleavage products p43/p41 and   
p18 (Lavrik et al., 2007). Overexpression of a short c-FLIP 
isoform, c-FLIPR (HeLa-CD95–FR cells), efficiently blocked 
procaspase-8a/b cleavage at the DISC. In these cells, only   JCB • VOLUME 190 • NUMBER 3 • 2010   380
Our mathematical model includes several simplifications to 
reduce the complexity of the model. It has been previously reported 
by  Hughes  et  al.  (2009)  that  procaspase-8a  and  procaspase-8b   
possess similar catalytic properties at the DISC. Therefore, pro-
caspase-8a and procaspase-8b were considered as one entity.   
As the first cleavage step, we modeled only processing to p43/p41. 
The processing of p55/p53 to p30 was neglected in our modeling, 
as the amount of p30 generated is 20 times lower than p43/p41 
(Fig. 1 C; Hoffmann et al., 2009). As previously mentioned,   
c-FLIPS and c-FLIPR were considered as one entity, as they 
inhibit caspase-8 activation in a similar way (Golks et al., 2005). 
Procaspase-10 activation was not considered, as it was reported to 
not contribute to the onset of apoptosis (Sprick et al., 2002).
To estimate the parameters of the model, we measured the 
absolute  concentrations  of  all  relevant  proteins.  We  applied 
quantitative Western blotting using recombinant proteins as con-
centration standards (Fig. S3 A). The resulting numbers of mole-
cules are presented in Table S1. Strikingly, the number of c-FLIP 
proteins in HeLa-CD95 cells was very low, suggesting a high   
affinity of c-FLIP proteins to the DISC, leading to high concen-
tration of c-FLIP proteins at the DISC as reported in previous 
studies (Chang et al., 2002; Lavrik et al., 2007).
The model was fitted to quantitative Western blot data   
of  procaspase-8  processing  in  HeLa-CD95,  HeLa-CD95–FL 
(Fig. 1 F), and HeLa-CD95–c-FLIP–deficient cells, which were 
generated using shRNA (Fig. S3 B). A good fit between model 
simulation (Fig. 2 B, solid lines) and experimental data (Fig. 2 B, 
dashed lines) could be achieved reproducing the cleavage of 
procaspase-8 into p43/p41 and p18. We concluded that the mathe-
matical model was well suited to quantitatively describe the pro-
cessing of procaspase-8 at the DISC.
The model predicts CD95L dose-dependent 
effects of c-FLIPL
Our experiments (Fig. 1) as well as data in previous literature 
(Bentele et al., 2004; Neumann et al., 2010) suggest nonlinear   
effects on procaspase-8 processing by c-FLIP proteins. Therefore, 
the question arose whether our model could describe how changes 
in the amount of c-FLIPL influenced processing of procaspase-8 
and CD95-mediated cell death. Fig. 3 shows procaspase-8 cleav-
age and cell death depending on the time and amount of c-FLIPL 
upon stimulation with 3 µg/ml (Fig. 3, A and C) and 30 ng/ml 
(Fig. 3, B and D) LZ-CD95L. Interestingly, the model could   
reproduce the CD95L dose-dependent effect of c-FLIPL on   
procaspase-8 cleavage. Our model predicted that a 20-fold c-FLIPL 
overexpression  would  reduce  procaspase-8  cleavage  and  cell 
death at a low concentration of LZ-CD95L but would accelerate 
procaspase-8 cleavage and cell death upon a high concentration. 
There are two reasons for this phenomenon: the first is that the 
ratio of c-FLIPL to caspase-8 at the DISC is dependent on the 
strength of the receptor signal. Because the total amount of c-FLIP 
in HeLa cells is very low (Table S1), the model predicted a deple-
tion of c-FLIP in the cytosol upon high CD95L stimulation be-
cause all c-FLIP had already been recruited to the DISC (Bentele 
et al., 2004; Lavrik et al., 2007). As a consequence, the relative 
amount of c-FLIP at the DISC is higher upon weak CD95 stimu-
lation than upon strong CD95 stimulation. The second reason is 
cell death was clearly slowed down after addition of 200 ng/ml 
LZ-CD95L in HeLa-CD95–FL cells. Even upon addition of   
3 µg/ml LZ-CD95L, cell death occurred slightly slower in   
HeLa-CD95–FL cells, although there was more procaspase-8 
processing initially (Fig. 1 F and Fig. S2 A).
Collectively, we observed nonlinear effects of c-FLIP 
overexpression  on  CD95-mediated  procaspase-8  processing 
and cell death. To explain these differential effects of c-FLIP on 
caspase-8 cleavage, we built a mathematical model of caspase-8 
processing at the CD95 DISC.
A mathematical model of procaspase-8 
activation at the DISC
The observation that c-FLIPL may either block or accelerate 
procaspase-8 cleavage depending on its concentration at the 
DISC and the strength of CD95 stimulation prompted us to ex-
plain these effects using a mathematical model. To generate a 
systems biology model of procaspase-8 activation at the DISC, 
we developed a mathematical model based on ordinary differ-
ential equations. The topology of the model is shown in Fig. 2 A.   
It involves binding of CD95L to CD95, followed by FADD   
recruitment, which leads to binding of DED proteins c-FLIP 
and procaspase-8.
We considered that procaspase-8 forms three types of di-
mers  at  the  DISC:  procaspase-8  homodimers,  procaspase-8/ 
c-FLIPL heterodimers, and procaspase-8/c-FLIPS/R heterodimers. 
Generation of procaspase-8 homodimers results in full process-
ing of procaspase-8 to its cleavage products p43/p41 and p18. 
Procaspase-8/c-FLIPL heterodimers are only processed to p43/
p41 and p43-FLIP in our model. This consideration is based on 
a previous study (Krueger et al., 2001) as well as our own ex-
perimental data. To this point, we have generated HeLa-CD95–
FL/R cells, which overexpress both the short (c-FLIPR) and the 
long c-FLIP isoforms. Therefore, the amount of procaspase-8   
at the DISC is reduced, and mainly procaspase-8/c-FLIPR and 
procaspase-8/c-FLIPL heterodimers are formed. In these cells, 
we observed processing of procaspase-8 at the DISC only to 
p43/p41 but not to p18 (Fig. S2 B). In our model, procaspase-8 
homodimers and procaspase-8/c-FLIPL heterodimers were cat-
alytically active and could process other procaspase-8 dimers. 
The third type of procaspase-8 dimers, procaspase-8/c-FLIPS/R 
heterodimers,  did  not  possess  any  catalytic  activity  and   
were not processed. Additionally, we introduced a turnover of 
procaspase-8 at the DISC in our mathematical model. Our as-
sumption was that once one procaspase-8 molecule had been 
completely cleaved, it could be replaced at the DISC by new 
procaspase-8  molecules  recruited  to  this  complex. This  was 
necessary to explain the observed data.
Finally, in our model, all active procaspase-8 cleav-
age products (p41/p43–procaspase-8 homodimers, p41/p43– 
procaspase-8/p43-FLIP  heterodimers,  and  (p10-p18)2  caspase-8 
heterotetramers) cleaved a universal apoptosis substrate (Fig. 2 A). 
Procaspase-8 homodimers were unable to cleave the apoptosis 
substrate, as it was reported that procaspase-8 activity itself is 
not sufficient to induce cell death (Kang et al., 2008). Cleavage 
of this substrate was assumed to lead directly to cell death and, 
consequently, was taken as readout for cell death.381 Interplay of c-FLIP proteins decides life or death • Fricker et al.
concentration of c-FLIPL, leading to an increase of caspase-8 
activity and apoptosis induction. The model predicted the high-
est amount of procaspase-8 cleavage and cell death to occur at a 
20–40-fold c-FLIPL overexpression at a concentration of 3 µg/ml 
LZ-CD95L and a 45-min time of stimulation (Fig. 3, A and C, 
right). Because the endogenous amount of c-FLIPL is very low 
(320 molecules per cell; Table S1), a 20–40-fold overexpres-
sion corresponds to 6,500–13,000 molecules per cell. This 
moderate  overexpression  could  be  achieved  after  transient 
transfection with a plasmid containing a histone H2 promoter 
followed by the coding sequence of GFP-IRES–c-FLIPL. The 
plasmid has a weak promoter, and the c-FLIPL cDNA was in-
serted  behind  and  not  in  front  of  the  IRES  sequence.  This   
construction results in a low overexpression of c-FLIPL. The re-
sulting level of expression of c-FLIPL was 20 times higher 
than in the control-transfected HeLa-CD95 cells (Fig. S4 A). 
The percentage of transfected cells was determined counting 
the  GFP-positive  cells  with  flow  cytometry.  The  fold  over-
expression of c-FLIPL was estimated by quantitative Western 
blotting. Dividing the total fold c-FLIPL overexpression by the 
that because of the high affinity of c-FLIP to FADD, it would re-
main bound to the DISC and could reduce a possible turnover of 
caspase-8 at the DISC. Therefore, although initial procaspase-8 
processing upon c-FLIPL overexpression is increased, c-FLIPL 
would block further caspase-8 activation. Two opposite effects of 
c-FLIPL, activation of procaspase-8 versus blockage of its turn-
over, result in nonlinear effects and lead to a narrow range of   
c-FLIPL concentrations, which result in sensitization toward CD95-
induced apoptosis (Fig. 3, C and D).
Collectively,  our  model  explained  the  CD95L  dose- 
dependent effects of c-FLIPL on procaspase-8 processing as well 
as on the onset of CD95-induced apoptosis. The next challenge 
was to test the predictions of the model in our cellular systems.
Experimental verification of model 
predictions: c-FLIPL both accelerated and 
slowed down cell death in a CD95L and  
c-FLIPL dose-dependent manner
Next, we tested whether we could confirm the predictions made 
by our model experimentally. First, we analyzed the optimal 
Figure  2.  A  mathematical  model  of  CD95 
signaling. (A) Scheme showing the topology   
of  the  mathematical  model.  CD95,  CD95L, 
and FADD are depicted in gray, the long and 
short isoforms of c-FLIP in blue, and caspase-8   
in green. At the DISC procaspase-8 homodimers,   
procaspase-8/c-FLIPL dimers and procaspase-8/ 
c-FLIPS/R dimers are formed. Red arrows indi-
cate catalytic processing. (B) Fitting of simulated   
data (solid lines) to measurement data (dashed 
lines) in HeLa-CD95 and HeLa-CD95–FL cells 
for procaspase-8 processing  upon  stimulation 
with 3 µg/ml LZ-CD95L. Numbers are given in 
thousands of molecules per cell. Procaspase-8 
is shown in red, p43/p41 in green, and p18 
in blue. Mean and SEM of three independent 
experiments are shown.JCB • VOLUME 190 • NUMBER 3 • 2010   382
cells  either  with  the  NES-IETD-mCherry  probe  and  the  H2 
GFP-IRES–c-FLIPL plasmid or the NES-IETD-mCherry probe 
and an empty control vector. GFP- (GFP
+) and mCherry-positive 
cells (mCherry
+) were analyzed in time-lapse microscopy, and 
the amount of mCherry translocating into the nucleus after 
CD95 stimulation was measured. In GFP
+mCherry
+ cells, we 
found a moderate increase in caspase-8 activity in comparison 
with GFP
mCherry
+ cells, as determined by cleavage of the 
caspase-8 activity probe in live cell imaging (Fig. 4 A).
To verify that this increase of caspase-8 activity led to an 
acceleration of cell death, we investigated death of the H2 GFP-
IRES–c-FLIPL–transfected cells versus the mCherry control–
transfected cells upon stimulation with 3 µg/ml LZ-CD95L. 
GFP
+ and mCherry
+ cells were determined with confocal micros-
copy followed by live cell imaging, and cell death was monitored 
by cell shrinkage and formation of apoptotic bodies (Fig. S4 C).   
In accordance with the model predictions, there was a sensitization 
percentage of transfected cells yielded the mean overexpres-
sion per transfected cell. The expression of the other main 
components of the CD95 system in these cells remained un-
altered (Fig. S4 B).
As the transfection efficiency was only 10%, we could 
not  analyze  the  effect  of  moderate  c-FLIPL  overexpression   
using Western blot analysis. Therefore, we decided to perform a 
single-cell analysis with time-lapse microscopy. To determine 
caspase-8 activity in the cells, we transfected them with a plas-
mid encoding a nuclear export signal (NES)–IETD-mCherry 
fusion protein. This protein consists of an NES followed by the 
peptide sequence IETD fused to mCherry via a linker and 
thereby served as a caspase-8 activity probe (Fig. S4 D). In un-
stimulated cells, this probe resided in the cytosol. Upon stimu-
lation with LZ-CD95L, procaspase-8 was activated and cleaved 
the probe after the IETD sequence, allowing mCherry to enter 
into  the  nucleus  (Fig.  S4  D). We  cotransfected  HeLa-CD95 
Figure 3.  The model predicts a CD95L dose-
dependent sensitization of c-FLIPL. (A, left) Pre-
diction of the amount of procaspase-8 processing 
depending on time and the concentration of 
c-FLIPL after stimulation with 3 µg/ml CD95L. 
Blue  indicates  low  amounts  of  procaspase-8 
processing,  and  red  indicates  high  amounts 
of  procaspase-8  cleavage.  (right)  Prediction 
of the amount of procaspase-8 processing de-
pending on the concentration of c-FLIPL after 
45 min of stimulation with 3 µg/ml CD95L. 
(B, left) Prediction of the amount of procaspase-8   
processing  depending  on  time  and  the   
concentration of c-FLIPL after stimulation with   
30  ng/ml  CD95L.  (right)  Prediction  of  the   
amount of procaspase-8 processing depend-
ing  on  the  concentration  of  c-FLIPL  after   
400 min of stimulation with 30 ng/ml CD95L. 
(C, left) Simulation of the amount of cell death 
depending on time and the concentration of 
c-FLIPL after stimulation with 3 µg/ml CD95L in 
HeLa-CD95 cells. (right) Predicted amount of 
cell death depending on the concentration of 
c-FLIPL after 45 min of stimulation with 3 µg/ml 
CD95L in HeLa-CD95 cells. (D, left) Simulation 
of the amount of cell death depending on time 
and the concentration of c-FLIPL after stimula-
tion with 30 ng/ml CD95L in HeLa-CD95 cells. 
(right) Prediction of the amount of cell death 
depending on the concentration of c-FLIPL after 
400 min of stimulation with 30 ng/ml CD95L 
in HeLa-CD95 cells. (A and B) The number of 
cleaved  procaspase-8  molecules  is  given  in 
thousands of molecules per cell. Dashed lines 
indicate the consequence of a 20-fold c-FLIPL 
overexpression, which is achieved with the H2 
GFP-IRES–c-FLIPL plasmid.383 Interplay of c-FLIP proteins decides life or death • Fricker et al.
For high overexpression levels of c-FLIPL, the model pre-
dicted a significant reduction of procaspase-8 processing and   
sensitivity toward CD95-induced apoptosis (Fig. 3, A and C).   
To test this prediction, we overexpressed c-FLIPL in high amounts. 
This was achieved after transient transfection of a plasmid encod-
ing c-FLIPL–IRES-GFP under control of a cytomegalovirus (CMV) 
promoter. 15% of GFP
+ cells were still alive after 70 min of stim-
ulation, whereas all control-transfected mCherry
+ cells were al-
ready dead at this time point (Fig. 4 E). This was in accordance 
with  the  model-based  prediction  that  a  drop  of  procaspase-8 
cleavage and cell death upon very high c-FLIPL expression would 
be observed (Fig. 3, A and C). Collectively, we could confirm   
the predictions made by the model and observed that the same 
amount of c-FLIPL can accelerate or slow down CD95-mediated 
cell death depending on the stimulating dose of CD95L.
Moderate c-FLIPL up-regulation slows down 
cell death in HeLa wild-type (wt) cells
So far, we have shown that the effect of c-FLIPL depends on 
the strength of CD95 stimulation and the amount of c-FLIPL. 
toward CD95-induced apoptosis upon moderate c-FLIPL over-
expression (Fig. 4 B).
Furthermore, we wanted to verify the predictions made 
by the model for a weak stimulation with 30 ng/ml LZ-CD95L. 
Already, a 20-fold up-regulation of c-FLIPL was predicted to 
lead to a reduction of both procaspase-8 processing and cell 
death after 400 min of stimulation (Fig. 3, B and D, right). 
Indeed, upon stimulation with 30 ng/ml LZ-CD95L, induc-
tion of cell death was slowed down in cells transfected with 
the H2 GFP-IRES–c-FLIPL plasmid, as determined with live 
cell imaging (Fig. 4 D). The same amount of c-FLIPL that 
sensitized HeLa-CD95 cells upon a stimulation with 3 µg/ml 
LZ-CD95L slowed down cell death upon stimulation with   
30  ng/ml  LZ-CD95L.  Upon  addition  of  500  ng/ml  LZ-
CD95L, almost no differences in cell death between control-
transfected  and  H2  GFP-IRES–c-FLIPL–transfected  cells 
were observed (Fig. 4 C). We concluded that upon c-FLIPL 
overexpression, there is a continuum from blocking cell death 
upon weak stimulation to accelerating induction of cell death 
upon strong stimulation.
Figure 4.  c-FLIPL accelerates or slows down 
CD95-induced  cell  death  in  a  CD95L  dose-
dependent  manner.  (A)  HeLa-CD95  cells 
were  transfected  with  a  plasmid  encoding 
the  NES-IETD-mCherry  probe  along  with  the 
H2  GFP-IRES–c-FLIPL  plasmid  or  an  empty 
control plasmid. 48 h after transfection, cells 
were  stimulated  with  LZ-CD95L.  The  graph 
shows  caspase-8  activity  probe  cleavage  of 
GFP
+mCherry
+ and GFP
mCherry
+ cells after 
addition  of  3  µg/ml  LZ-CD95L.  (B–D)  HeLa-
CD95  cells  were  transfected  with  the  H2   
GFP-IRES–c-FLIPL (B–D), the CMV c-FLIPL–IRES-GFP 
(E), or an mCherry-encoding control plasmid. 
48 h after transfection, LZ-CD95L was added 
to the cells. The graphs in B and E show cell 
death of GFP
+ and mCherry
+ cells after addi-
tion of 3 µg/ml LZ-CD95L. The graphs in C 
and D show cell death of GFP
+ and mCherry
+  
cells after addition of 500 ng/ml and 30 ng/ml   
LZ-CD95L, respectively. Mean and SEM of four 
(A and B) or three (C–E) independent experi-
ments are shown. *, P < 0.05.JCB • VOLUME 190 • NUMBER 3 • 2010   384
Discussion
So far, the effect of c-FLIPL on DR-induced cell death has been 
unclear. Although several studies showed that c-FLIPL acceler-
ates procaspase-8 processing at the DISC (Chang et al., 2002; 
Micheau et al., 2002), this did not necessarily lead to a sensiti-
zation of cells toward DR-induced apoptosis. Chang et al. (2002) 
To  further  verify  the  proposed  mechanism  by  testing  the 
model predictions for yet another scenario, we investigated 
the effect of c-FLIPL in cells that express reduced amounts of 
CD95. The model predicted that in HeLa wt cells, which 
have an 10 times lower CD95 expression than HeLa-CD95 
cells, a 20-fold c-FLIPL overexpression led to a reduction in 
cell death after 350 min of stimulation with 3 µg/ml LZ-
CD95L (Fig. 5 A). After 350 min of stimulation with 3 µg/ml 
LZ-CD95L,  30%  of  H2  GFP-IRES–c-FLIPL–transfected 
cells were still alive, as determined with live cell imaging, in 
contrast  to  only  10%  survival  of  control-transfected  cells 
(Fig. 5 B). This is in agreement with the model prediction 
and  with  previous  results  (Sharp  et  al.,  2005). Therefore, 
moderate c-FLIPL overexpression in HeLa wt reduced CD95-
induced cell death.
c-FLIPS/R promotes the c-FLIPL–sensitizing 
effect on CD95-induced cell death
We observed that we could sensitize HeLa-CD95 cells to 
CD95-induced death with overexpression of c-FLIPL only   
to a minor extent (Fig. 4). To explain this phenomenon, we   
suggest  that  processing  of  procaspase-8  at  the  DISC  in   
HeLa-CD95 cells is relatively fast. Therefore, accelerating 
procaspase-8 cleavage at the DISC with c-FLIPL overexpres-
sion has only marginal effects. To test this hypothesis, we 
searched  for  a  system  in  which  procaspase-8  processing   
at  the  DISC  would  be  slowed  down.  HeLa-CD95–FS  and 
HeLa-CD95–FR cells with a high amount of short c-FLIP iso-
forms ideally suited this scenario, as processing of procaspase-8   
in these cells occurs much slower than in the absence of   
c-FLIPS/R (Fig. 1 B). The model predicted that in HeLa-
CD95–FR and HeLa-CD95–FS cells, c-FLIPL overexpression 
would lead to a strong increase in both procaspase-8 process-
ing  and  cell  death  upon  addition  of  3  µg/ml  LZ-CD95L   
(Fig. 6 A and Fig. S5). To verify this prediction, we com-
pared  procaspase-8  cleavage  in  stable  HeLa-CD95–FR/L  
cells with HeLa-CD95–FR cells on Western blots. Indeed, 
procaspase-8 processing to p43/p41 and p18 was visible in 
HeLa-CD95–FR/L cells already 30 min after addition of 3 µg/ml 
LZ-CD95L but was absent in HeLa-CD95–FR cells at this 
time point (Fig. 6 B). We could also confirm an increase in 
sensitivity  of  HeLa-CD95–FR/L  as  compared  with  HeLa-
CD95–FR cells toward CD95-induced cell death, as measured 
with flow cytometry (Fig. 6 C).
Next,  we  analyzed  CD95-induced  death  in  HeLa-
CD95–FS cells upon c-FLIPL overexpression using live cell 
imaging. HeLa-CD95–FS cells were transfected transiently 
with c-FLIPL using both promoters CMV and H2, respec-
tively. For both scenarios, we observed significant sensitiza-
tion  toward  CD95-induced  apoptosis  (Fig.  6,  D  and  E).   
90 min after addition of LZ-CD95L, only 40% of the cells 
transfected with a control plasmid were dead. In contrast, 
75% of the c-FLIPL-transfected cells had already undergone   
apoptosis at this time point. Thus, we confirmed the model 
predictions and demonstrated that the sensitizing effect of   
c-FLIPL toward CD95-induced cell death is strongly increased   
in the presence of c-FLIPS/R.
Figure 5.  Moderate c-FLIPL overexpression blocks cell death in HeLa wt 
cells. (A, top) Prediction of the amount of cell death depending on time 
and concentration of c-FLIPL after stimulation with 3 µg/ml CD95L in HeLa 
wt cells. (bottom) Prediction of the amount of cell death depending on the 
concentration of c-FLIPL after 350 min of stimulation with 3 µg/ml CD95L 
in HeLa wt cells. (B) HeLa wt cells were transfected with the H2 GFP-IRES– 
c-FLIPL or an mCherry-encoding control plasmid. 48 h after transfection, 
LZ-CD95L was added to the cells. The graph shows cell death of GFP
+ and 
mCherry
+ cells after addition of 3 µg/ml LZ-CD95L. Mean and SEM of 
three independent experiments are shown. *, P value < 0.05.385 Interplay of c-FLIP proteins decides life or death • Fricker et al.
(Chang  et  al.,  2002),  and  after  recruitment  to  the  DISC,   
it might remain bound, blocking turnover of procaspase-8 at the 
DISC. These two opposite effects result in the nonlinearity and 
lead to a narrow range of c-FLIPL concentrations, which result 
in sensitization toward CD95-induced apoptosis.
Furthermore, we show that c-FLIPR/S has the potential 
to modulate the strength of the sensitizing function of c-FLIPL 
(Fig. 7). In cells with high c-FLIPR/S levels, c-FLIPL has a 
strong sensitizing effect. So far, c-FLIPR/S have always been 
considered as molecules, which simply block procaspase-8 
activation (Krueger et al., 2001; Golks et al., 2005; Ueffing   
et al., 2008; Kaunisto et al., 2009). The newly discovered 
function  of  c-FLIPR/S  offers  a  novel  possibility  to  further 
modulate CD95 signaling. This is especially important given 
that a lot of tumor cells regulate CD95 signaling by changing 
c-FLIP amounts and the ratio of c-FLIPS to c-FLIPL. There-
fore, subtle changes in the stoichiometry of c-FLIP proteins 
at the DISC might significantly change the phenotype of the 
cells from resistant to sensitive. Moreover, we show that con-
sidering c-FLIPR/S as molecules that just block procaspase-8 
processing  might  be  too  simplistic.  In  addition,  our  work 
proposed that small amounts of c-FLIPL sensitize cells, whereas 
high amounts block CD95-induced cell death. However, Sharp 
et al. (2005) showed in quite a few cell lines that down-regulation 
of c-FLIPL leads to sensitization toward DR-induced apoptosis. 
The  authors  concluded  that  c-FLIPL  exclusively  blocks  cell 
death. Our results demonstrate that the effect of c-FLIPL on   
induction of cell death is CD95L dose dependent. The same 
amount of c-FLIPL can slow down induction of cell death at 
weak receptor stimulation but accelerates cell death upon stim-
ulation with high doses of CD95L. This complex behavior 
shows that understanding of the effects of c-FLIPL is possible 
only  considering  the  exact  concentration  of  the  DISC  com-
ponents, e.g., amounts of CD95L and active DISCs as well as 
concentration of c-FLIPL at the DISC, and also provides an ex-
planation for different results in different cellular systems 
(Chang et al., 2002; Sharp et al., 2005).
Our model can also explain two opposite effects of c-FLIPL 
on  procaspase-8  activation  and  CD95-induced  apoptosis.   
c-FLIPL can either promote the activation of procaspase-8 or 
block the binding of procaspase-8 and, furthermore, procaspase-8 
turnover at the DISC. c-FLIPL has a high affinity to the DISC 
Figure  6.  c-FLIPL  sensitizes  cells  with  high   
c-FLIPS/R levels. (A, left) Prediction of the amount 
of  cell  death  depending  on  time  and  the   
concentration of c-FLIPL after stimulation with 
3  µg/ml  CD95L  in  HeLa-CD95–FR  cells. 
(right) Prediction of the amount of cell death 
depending on the concentration of c-FLIPL after 
120 min of stimulation with 3 µg/ml CD95L in   
HeLa-CD95–FR cells. (B) HeLa-CD95–FR/L and 
HeLa-CD95–FR  cells  were  stimulated  with   
3 µg/ml LZ-CD95L for the indicated time points. 
Total  cellular  lysates  were  analyzed  using 
Western blotting (WB) with antibodies against 
caspase-8, c-FLIP, and actin. One representa-
tive experiment out of three is shown. White 
lines indicate that intervening lanes have been 
spliced out. (C) HeLa-CD95–FR/L (black bars) 
and  HeLa-CD95–FR  (white  bars)  cells  were 
stimulated with the indicated amounts of LZ-
CD95L.  Specific  cell  death  was  determined 
after 5 h of CD95 stimulation with PI stain and 
flow cytometry. (D and E) HeLa-CD95–FS cells 
were transfected with the H2 GFP-IRES–c-FLIPL 
(D), CMV c-FLIPL–IRES-GFP (E), or an mCherry-
encoding control plasmid. 48 h after transfec-
tion, CD95L was added to the cells. The graph 
shows cell death of GFP
+ and mCherry
+ cells 
after  addition  of  3  µg/ml  LZ-CD95L.  Mean 
and  SEM  of  three  independent  experiments 
are shown. *, P < 0.05.JCB • VOLUME 190 • NUMBER 3 • 2010   386
Tschopp, 2004; Dohrman et al., 2005; Budd et al., 2006; Golks 
et al., 2006). Therefore, understanding of the quantitative stoi-
chiometry of c-FLIP proteins and generation of c-FLIP cleav-
age products at the DISC might potentially lead to new insights 
in the understanding of life/death decisions at CD95.
Our model explains the regulation of procaspase-8 activa-
tion by c-FLIP proteins in HeLa cells, which overexpress CD95. 
With exception of the first model of the CD95-induced apop-
tosis (Bentele et al., 2004), which was performed using B lym-
phoblastoid cells, most systems biology models of apoptosis   
currently published use HeLa cells as a cellular system (Lavrik 
et al., 2009). Previous studies defined the mitochondrial outer 
membrane permeabilization regulation using HeLa cells (Rehm 
et al., 2006, 2009). Several sophisticated models of TRAIL- 
induced apoptosis using HeLa cells were also previously devel-
oped (Albeck et al., 2008a,b; Spencer et al., 2009). Therefore, 
up to now, using HeLa cells is a well-defined experimental setup 
for systems biology studies. The future challenge will be to de-
velop systems biology models toward understanding of apop-
tosis regulation in various other cell types. Especially important 
will be the understanding of primary cancer cells.
We have discovered a new view of caspase-8 activation by 
c-FLIP proteins. Another question to address in the future will be 
the contribution of c-FLIP proteins to procaspase-10 activation at 
the DISC. Procaspase-10 has been reported to lack a major im-
pact on apoptosis induction (Sprick et al., 2002). However, these 
findings might only apply to certain cell types and low levels of 
procaspase-10 in these cells. Therefore, the investigation of all 
shows that looking at the effects of c-FLIPS/R and c-FLIPL as 
if they were components of separate signaling pathways can 
be misleading, as this approach ignores the interplay of those 
two molecules.
For the first time, our model has described the activation of 
procaspase-8 at the DISC and apoptosis with the generation of dif-
ferent homo- and heterodimers of procaspase-8 at the DISC lead-
ing to the cell death. Our model also introduced a direct readout for 
the rate of cell death. The active procaspase-8 cleavage products 
p43/p41  procaspase-8  homodimer,  p43/p41-p43-FLIP  hetero-
dimer, and the (p10/p18)2 heterotetramer could cleave an apoptosis 
substrate leading to cell death. Interestingly, in our model, the   
activity of the p43/p41 procaspase-8 homodimer toward the apop-
tosis substrate was estimated to be roughly five times as high as 
that of the p43/p41-p43-FLIP heterodimer. A similar decrease in 
activity of the p43/p41 homodimer compared with the heterodimer 
was also proposed by Yu et al. (2009). The activity of the caspase-8 
heterotetramer was much less than the activity of one of the 
homodimers. This is in accordance with the finding of Hughes   
et al. (2009). They proposed that the second cleavage step of 
procaspase-8 processing might reduce the activity of the molecule.   
Importantly, setting the activities of the procaspase-8 proteins in this 
way, we could reproduce the experimental data well (Figs. 4–6).
Another important role in the regulation of life/death deci-
sions at the DISC is the induction of other nonapoptotic path-
ways via CD95, such as NF-B (Budd et al., 2006; Neumann   
et al., 2010). c-FLIP proteins have been reported to be crucial 
regulators of NF-B activity (Kataoka et al., 2000; Kataoka and 
Figure 7.  c-FLIPL sensitizes cells with high c-FLIPS/R levels. The scheme shows the effect of c-FLIPL in cells with high c-FLIPS/R levels. Caspase-8 is shown in 
red, and c-FLIP is shown in green. (left) Procaspase-8 processing occurs slowly in cells with high c-FLIPS/R amounts. (right) Additional expression of c-FLIPL 
leads to formation of procaspase-8/c-FLIPL heterodimers, which have a higher activity than homodimers and are able to cleave and activate procaspase-8, 
leading to cell death.387 Interplay of c-FLIP proteins decides life or death • Fricker et al.
incubated with the primary antibody in PBS/Tween overnight at 4°C. Blots 
were developed with a chemoluminescence method according to the man-
ufacturer’s protocol (PerkinElmer).
DISC immunoprecipitation
10
7 HeLa-CD95 cells were lysed in lysis buffer A with or without stimula-
tion, divided into two equal parts, and DISC immunoprecipitation was per-
formed using 5 µg anti-CD95 antibody (anti–APO-1) with 30 µl protein 
A–Sepharose.  Immunoprecipitations  were  performed  overnight  at  4°C, 
then beads were washed five times with 20 vol of lysis buffer and subjected 
to Western blot analysis as described in the previous paragraph.
Microscope image acquisition
Cells  were  cultured  in  8-well  Laboratory-Tek–chambered  cover  glasses 
(Thermo Fisher Scientific). During imaging, cells were maintained at 37°C 
in DME without phenol red and complemented with 20 mM Hepes buffer 
and 10% FCS. We used a laser-scanning confocal microscope (TCS SP2; 
Leica) with a 63× 1.4 NA oil immersion lens and a camera (DC300FX; 
Leica) for image acquisition. For excitation, the laser wavelength was set to 
488 nm for GFP and 594 nm for mCherry. The recording spectrum was 
498–535 nm for GFP and 604–686 nm for mCherry. Image acquisition 
was performed using confocal software (Leica). Image analysis was per-
formed using ImageJ (National Institutes of Health). To measure cell death of 
GFP-IRES–c-FLIPL– versus mCherry control–transfected cells, we determined 
which cells were GFP
+ or mCherry
+ with fluorescence microscopy. Then, 
CD95L was added to the cells. Cell fate of mCherry
+ and GFP
+ cells was 
measured with live cell imaging. To measure cleavage of the caspase-8 ac-
tivity, probe cells were cotransfected with a GFP-IRES–c-FLIPL plasmid plus 
the NES-IETD-mCherry probe or the NES-IETD-mCherry probe plus an empty 
control vector. Cleavage of the caspase-8 activity probe was determined by 
translocation of mCherry to the nucleus in confocal microscopy. To measure 
mCherry translocation to the nucleus, the mean fluorescence intensity (MFI) 
of the nucleus and cytoplasm was determined using ImageJ. The following 
formula was applied to calculate the translocation R(t): R(t) = [MFI (nucleus)  
MFI (cytoplasm)]/[MFI (nucleus) + MFI (cytoplasm)]  R(0).
Cell death assay
Cells were plated and treated as indicated with LZ-CD95L for indicated   
periods of time and 1 µg/ml propidium iodide (PI) for 30 min. Cell death 
was assessed by PI uptake and quantified with a flow cytometer (Cytomics 
FC 500 MPL; Beckman Coulter).
Statistical methods
Student’s t test was applied to test for significance of differences in cell 
death between cell lines as measured by live cell imaging.
Mathematical modeling
Modeling was performed using the SBtoolbox (Schmidt and Jirstrand, 2006) 
in combination with Matlab (MathWorks). For local parameter fitting, a sim-
plex algorithm was used. For parameter fitting, we used data from quantita-
tive Western blots for processing of procaspase-8. Additionally, proteins 
amounts were set in the model according to measured data shown in Table S1 
with acceptance of a 20% deviation. After 1,000 times of local parameter 
estimation with random start values, best fits were analyzed. The model is 
available in SBtoolbox model format as Supplemental data.
Online supplemental material
Fig. S1 shows characterization of stable cell lines overexpressing differ-
ent c-FLIP isoforms. Fig. S2 shows the effect of c-FLIPL on procaspase-8   
processing and cell death. Fig. S3 shows protein quantification with West-
ern  blots  and  the  effect  of  c-FLIP  down-regulation  in  HeLa-CD95  cells.   
Fig. S4 shows live cell imaging of HeLa-CD95 cells. Fig. S5 shows that the 
model predicts an increase in procaspase-8 processing upon c-FLIPL over-
expression in HeLa-CD95–FR cells. Table S1 shows mean protein numbers   
per cell in HeLa-CD95 and c-FLIP–overexpressing HeLa-CD95 cells. Ad-
ditional supplementary data shows the CD95 signaling model as an SB-
toolbox file. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201002060/DC1.
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DED proteins of the DISC, procaspase-8, -10, and c-FLIP should 
be the focus of future studies.
Collectively, whether c-FLIPL accelerates or slows down 
DR-induced cell death does not only depend on its amount but 
also on the cell type and the strength of receptor stimulation. These 
findings explain why different investigators came to completely 
different conclusions and can resolve the contradictions reported 
in recent literature (Chang et al., 2002; Sharp et al., 2005).
Materials and methods
Cell lines
HeLa-CD95  was  generated  by  selection  with  20  ng/ml  puromycin   
according to standard protocols. Stable c-FLIPL and c-FLIPR cell lines were 
selected with 100 µg/ml G418 and 100 µg/ml zeocin, respectively. HeLa-
CD95 cells were maintained in DME (Life Technologies), 10 mM Hepes 
(Life Technologies), 50 µg/ml gentamycin (Life Technologies), and 10% 
FCS (Life Technologies) in 5% CO2. Transfections were performed using   
Lipofectamine 2000 (Invitrogen).
DNA constructs
For stable CD95 overexpression, CD95 cDNA was cloned into a pIRE-
Spuro3  plasmid  (Takara  Bio  Inc.).  To  generate  cells  stably  expressing   
c-FLIPL, the coding sequence of c-FLIPL was cloned in the pIRESneo3 vector 
(Takara Bio Inc.). For stable c-FLIPR expression, we used a pEF4 plasmid (In-
vitrogen). To generate the c-FLIPL–IRES-GFP plasmid, the neomycin-resistance 
sequence of the pIRESneo3 plasmid was replaced by GFP. For the c-FLIP kinase-
dead plasmid, the following sequence was cloned into a vector (pSilencer 
3.1-H1; Applied Biosystems): 5-GATCCGCAAGGAGAAGAGTTTCTTCT-
CAAGAGAAAGAAACTCTTCTCCTTGCTTTTTTGGAAA-3. The c-FLIP 
targeting sequence was 5-GCAAGGAGAAGAGTTTCTT-3. To construct 
the NES-IETD-mCherry caspase-8 activity probe, an NES was fused to the 
caspase-8 cleavage sequence IETD followed by a linker, leading to the 
sequence  MNLVDLQKKLEELELDEQQTGGPIETDSGGGGG.  This  sequence 
was then fused to mCherry. To obtain a plasmid encoding for GFP-IRES– 
c-FLIPL under a histone H2 promoter, we amplified a GFP-IRES sequence with 
the following primers: (top) 5-GCGGCCTAGCTAGCGCTTAAGGCCTG-3 
and (bottom) 5-GGGTTGCTAGCGGGTTGTGGCAAGCTTA-3. Addition-
ally, we used a c-FLIPL coding sequence that was flanked at 3 with an NheI 
sticky end and at 5 with an NotI sticky end. The empty plasmid containing 
an H2 promoter was digested with NheI and NotI in the multiple-cloning 
site. After digestion with NheI, the PCR fragment was ligated together with 
the c-FLIPL–encoding fragment into the plasmid containing an H2 promoter. 
The coding sequence of LZ-CD95L (Walczak et al., 1999) was cloned into 
a pIRESpuro3 plasmid (Takara Bio Inc.).
Antibodies and reagents
Anti–caspase-8 monoclonal antibody C15 (mouse IgG2b) recognizes the 
p18 subunit of caspase-8 (Scaffidi et al., 1997). Anti-FLIP monoclonal anti-
body NF6 (mouse IgG1) recognizes the N-terminal part of c-FLIP (Scaffidi 
et al., 1999). Anti–APO-1 (anti-CD95) is an agonistic monoclonal anti-
body (IgG3) recognizing an epitope on the extracellular part of CD95 
(APO-1/Fas; Trauth et al., 1989). Additionally, we used a polyclonal C3 
antibody (Cell Signaling Technology), C2-10 anti-PARP antibody (BD), and 
the C20 monoclonal CD95 antibody (Santa Cruz Biotechnology, Inc.). 
Horseradish peroxidase–conjugated goat anti–mouse IgG1, -2a, and -2b 
were obtained from SouthernBiotech. The coding sequence of LZ-CD95L 
(Walczak et al., 1999) was cloned into a pIRESpuro3 plasmid (Takara Bio 
Inc.). Recombinant LZ-CD95L was produced using 293T cells stably trans-
fected with this vector. All chemicals used were of analytical grade and 
purchased from Merck or Sigma-Aldrich.
Analysis of total cellular lysates
3 × 10
5 cells were either treated with indicated amounts of LZ-CD95L for 
indicated periods of time at 37°C or left untreated, washed twice in 1x 
PBS, and lysed subsequently in lysis buffer A (30 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride [Sigma-
Aldrich], protease inhibitor cocktail, 1% Triton X-100 [Serva], and 10% 
glycerol). Total cellular lysates were analyzed using SDS-PAGE (Invitrogen). 
Proteins  were  transferred  to  Hybond  nitrocellulose  membrane  using   
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